219 related articles for article (PubMed ID: 27616655)
1. Risk factors for bacteremia and central line-associated blood stream infections in children with acute myelogenous leukemia: A single-institution report.
Rogers AE; Eisenman KM; Dolan SA; Belderson KM; Zauche JR; Tong S; Gralla J; Hilden JM; Wang M; Maloney KW; Dominguez SR
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27616655
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for central line-associated bloodstream infection in pediatric intensive care units.
Wylie MC; Graham DA; Potter-Bynoe G; Kleinman ME; Randolph AG; Costello JM; Sandora TJ
Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1049-56. PubMed ID: 20731595
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for central line-associated bloodstream infections in the era of best practice.
Lissauer ME; Leekha S; Preas MA; Thom KA; Johnson SB
J Trauma Acute Care Surg; 2012 May; 72(5):1174-80. PubMed ID: 22673242
[TBL] [Abstract][Full Text] [Related]
4. Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Mar; 60(8):243-8. PubMed ID: 21368740
[TBL] [Abstract][Full Text] [Related]
5. Ambulatory pediatric oncology CLABSIs: epidemiology and risk factors.
Rinke ML; Milstone AM; Chen AR; Mirski K; Bundy DG; Colantuoni E; Pehar M; Herpst C; Miller MR
Pediatr Blood Cancer; 2013 Nov; 60(11):1882-9. PubMed ID: 23881643
[TBL] [Abstract][Full Text] [Related]
6. Impact of mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) on central line-associated bloodstream infections (CLABSIs) in department of hematology at single university hospital in Japan.
Kato Y; Hagihara M; Kurumiya A; Takahashi T; Sakata M; Shibata Y; Kato H; Shiota A; Watanabe H; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jan; 24(1):31-35. PubMed ID: 29066217
[TBL] [Abstract][Full Text] [Related]
7. Central line-associated bloodstream infection in childhood malignancy: Single-center experience.
Miliaraki M; Katzilakis N; Chranioti I; Stratigaki M; Koutsaki M; Psarrou M; Athanasopoulos E; Stiakaki E
Pediatr Int; 2017 Jul; 59(7):769-775. PubMed ID: 28376269
[TBL] [Abstract][Full Text] [Related]
8. The descriptive epidemiology of central line-associated bloodstream infection among patients in non-intensive care unit settings.
Tedja R; Gordon SM; Fatica C; Fraser TG
Infect Control Hosp Epidemiol; 2014 Feb; 35(2):164-8. PubMed ID: 24442079
[TBL] [Abstract][Full Text] [Related]
9. The effect of multiple concurrent central venous catheters on central line-associated bloodstream infections.
Concannon C; van Wijngaarden E; Stevens V; Dumyati G
Infect Control Hosp Epidemiol; 2014 Sep; 35(9):1140-6. PubMed ID: 25111922
[TBL] [Abstract][Full Text] [Related]
10. Central Line-Associated Blood Stream Infections and Non-Central Line-Associated Blood Stream Infections Surveillance in Canadian Tertiary Care Neonatal Intensive Care Units.
Zipursky AR; Yoon EW; Emberley J; Bertelle V; Kanungo J; Lee SK; Shah PS;
J Pediatr; 2019 May; 208():176-182.e6. PubMed ID: 30853200
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Risk Factors of Long-term Central Venous Catheter-associated Bloodstream Infections in Children.
Moon HM; Kim S; Yun KW; Kim HY; Jung SE; Choi EH; Lee HJ
Pediatr Infect Dis J; 2018 May; 37(5):401-406. PubMed ID: 29194165
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
[TBL] [Abstract][Full Text] [Related]
13. CLABSI Risk Factors in the NICU: Potential for Prevention: A PICNIC Study.
Dahan M; O'Donnell S; Hebert J; Gonzales M; Lee B; Chandran AU; Woolsey S; Escoredo S; Chinnery H; Quach C
Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1446-1452. PubMed ID: 27609629
[TBL] [Abstract][Full Text] [Related]
14. Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy.
Tsai HC; Huang LM; Chang LY; Lee PI; Chen JM; Shao PL; Hsueh PR; Sheng WH; Chang YC; Lu CY
J Microbiol Immunol Infect; 2015 Dec; 48(6):639-46. PubMed ID: 25311403
[TBL] [Abstract][Full Text] [Related]
15. Lessons learned from a hospital-wide review of blood stream infections for paediatric central line-associated blood stream infection prevention.
Campbell AJ; Blyth CC; Hewison CJ; Chen YP; Gough L; Goff Z; Bowen AC
J Paediatr Child Health; 2019 Jun; 55(6):690-694. PubMed ID: 30315622
[TBL] [Abstract][Full Text] [Related]
16. Central-line-associated bloodstream infections and central-line-associated non-CLABSI complications among pediatric oncology patients.
Kelada AS; Foster TB; Gagliano GC; Worley S; Tang A; Arakoni VA; Foster CB
Infect Control Hosp Epidemiol; 2023 Mar; 44(3):377-383. PubMed ID: 35475427
[TBL] [Abstract][Full Text] [Related]
17. Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program.
McDonald MK; Culos KA; Gatwood KS; Prow C; Chen H; Savani BN; Byrne M; Kassim AA; Engelhardt BG; Jagasia M; Satyanarayana G
Biol Blood Marrow Transplant; 2018 Oct; 24(10):2081-2087. PubMed ID: 29753159
[TBL] [Abstract][Full Text] [Related]
18. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings.
Ardura MI; Bibart MJ; Mayer LC; Guinipero T; Stanek J; Olshefski RS; Auletta JJ
J Pediatr Hematol Oncol; 2021 Jan; 43(1):e64-e72. PubMed ID: 32960848
[TBL] [Abstract][Full Text] [Related]
19. Changes in Central Line-Associated Bloodstream Infection Rates Among Children With Immune Compromised Conditions: An 11-Year Review.
Linder LA; Gerdy C; Jo Y; Wilson A
J Pediatr Oncol Nurs; 2018; 35(6):382-391. PubMed ID: 29665727
[TBL] [Abstract][Full Text] [Related]
20. Characteristics, costs, and outcomes associated with central-line-associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals.
Yu KC; Jung M; Ai C
Infect Control Hosp Epidemiol; 2023 Dec; 44(12):1920-1926. PubMed ID: 37424226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
